Haemonetics (HAE) Long-Term Deferred Tax (2010 - 2026)

Haemonetics has reported Long-Term Deferred Tax for 17 years, with the latest figure at $9.5 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax rose 22.02% year-over-year to $9.5 million; the trailing twelve-month figure through Mar 2026 stood at $9.5 million (up 22.02% YoY), and the FY2026 full-year result was $9.5 million, up 22.02% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $9.5 million, up from $7.3 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $9.5 million in Q1 2026, with the low at $4.3 million in Q4 2022.
• Average Long-Term Deferred Tax over 5 years is $6.6 million, with a median of $6.7 million recorded in 2022.
• Year-over-year, Long-Term Deferred Tax dropped 29.39% in 2022 and jumped 92.18% in 2024.
• Tracing HAE's Long-Term Deferred Tax over 5 years: stood at $4.8 million in 2022, then rose by 4.71% to $5.1 million in 2023, then surged by 57.79% to $8.0 million in 2024, then slipped by 8.39% to $7.3 million in 2025, then rose by 29.91% to $9.5 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $9.5 million (Q1 2026), $7.3 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.

Peer Comparison